Recombinant multi-species NMI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NMI protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
NMYC interactor (NMI) encodes a protein that interacts with NMYC and CMYC (two members of the oncogene Myc family), and other transcription factors containing a Zip, HLH, or HLH-Zip motif. The NMI protein also interacts with all STATs except STAT2 and augments STAT-mediated transcription in response to cytokines IL2 and IFN-gamma. The NMI mRNA has low expression levels in all human fetal and adult tissues tested except brain and has high expression in cancer cell line-myeloid leukemias. [provided by RefSeq, Jul 2008]
The Alternative Names of target: N-myc and STAT interactor,N-myc-interactor,NMI,Nmi

Target products collectionGo to NMI products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1126-Ag-1/ GM-Tg-hg-SE1126-Ag-2 Human NMI protein Human
GM-Tg-rg-SE1126-Ag-1/ GM-Tg-rg-SE1126-Ag-2 Rat NMI protein Rat
GM-Tg-mg-SE1126-Ag-1/ GM-Tg-mg-SE1126-Ag-2 Mouse NMI protein Mouse
GM-Tg-cynog-SE1126-Ag-1/ GM-Tg-cynog-SE1126-Ag-2 Cynomolgus/Rhesus macaque NMI protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1126-Ag-1/ GM-Tg-felg-SE1126-Ag-2 Feline NMI protein Feline
GM-Tg-cang-SE1126-Ag-1/ GM-Tg-cang-SE1126-Ag-2 Canine NMI protein Canine
GM-Tg-bovg-SE1126-Ag-1/ GM-Tg-bovg-SE1126-Ag-2 Bovine NMI protein Bovine
GM-Tg-equg-SE1126-Ag-1/ GM-Tg-equg-SE1126-Ag-2 Equine NMI protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1126-Ag-1/ GM-Tg-hg-SE1126-Ag-2; GM-Tg-rg-SE1126-Ag-1/ GM-Tg-rg-SE1126-Ag-2;
GM-Tg-mg-SE1126-Ag-1/ GM-Tg-mg-SE1126-Ag-2; GM-Tg-cynog-SE1126-Ag-1/ GM-Tg-cynog-SE1126-Ag-2;
GM-Tg-felg-SE1126-Ag-1/ GM-Tg-felg-SE1126-Ag-2; GM-Tg-cang-SE1126-Ag-1/ GM-Tg-cang-SE1126-Ag-2;
GM-Tg-bovg-SE1126-Ag-1/ GM-Tg-bovg-SE1126-Ag-2; GM-Tg-equg-SE1126-Ag-1/ GM-Tg-equg-SE1126-Ag-2
Products Name NMI protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NMI
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NMI protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.